Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.
Journal: Journal of vitreoretinal diseases
Published: October 20, 2025
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World Practice.
Journal: Journal of vitreoretinal diseases
Published: August 14, 2025
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.
Journal: Journal of vitreoretinal diseases
Published: December 10, 2024
Bevacizumab First in DRCR Protocol AC vs Real-World Physician Treatment Choice for Diabetic Macular Edema: Two-Year Cost Analysis.
Journal: Journal of vitreoretinal diseases
Published: November 14, 2024
Opportunity Cost of Vitreoretinal Surgeries.
Journal: Journal of vitreoretinal diseases
Published: November 06, 2023
Evolving Treatment Patterns in Diabetic Macular Edema Between 2015 and 2020.
Journal: Journal of vitreoretinal diseases
Published: May 15, 2023
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care.
Journal: Journal of vitreoretinal diseases
Published: April 03, 2023
The Broader Economic Value of Treatment for Diabetic Macular Edema.
Journal: Diabetes care
Published: December 28, 2022
Trends in Medicare Reimbursement for Common Vitreoretinal Procedures: 2011 to 2020.
Journal: Ophthalmology
Published: January 06, 2022
Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis.
Journal: Journal of vitreoretinal diseases
Published: October 04, 2021
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their Patients.
Journal: Journal of vitreoretinal diseases
Published: September 01, 2021
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Journal: Journal of vitreoretinal diseases
Published: August 14, 2020
Last Updated: 09/26/2026